TOBAM’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-353
| Closed | -$115K | – | 250 |
|
|
2025
Q2 | $115K | Sell |
353
-3,013
| -90% | -$834K | 0.04% | 136 |
|
|
2025
Q1 | $909K | Sell |
3,366
-8,418
| -71% | -$2.16M | 0.39% | 71 |
|
|
2024
Q4 | $2.77M | Sell |
11,784
-19,683
| -63% | -$5.18M | 0.85% | 42 |
|
|
2024
Q3 | $8.65M | Buy |
31,467
+1,736
| +6% | +$452K | 1.58% | 20 |
|
|
2024
Q2 | $7.22M | Sell |
29,731
-39,331
| -57% | -$6.21M | 1.13% | 32 |
|
|
2024
Q1 | $10.3M | Sell |
69,062
-21,979
| -24% | -$3.67M | 0.93% | 38 |
|
|
2023
Q4 | $17.4M | Sell |
91,041
-12,003
| -12% | -$2.04M | 1.52% | 28 |
|
|
2023
Q3 | $18.2M | Sell |
103,044
-5,584
| -5% | -$1.07M | 1.46% | 27 |
|
|
2023
Q2 | $20.6M | Sell |
108,628
-18,132
| -14% | -$3.59M | 1.56% | 26 |
|
|
2023
Q1 | $25.4M | Buy |
126,760
+10,712
| +9% | +$2.25M | 1.67% | 23 |
|
|
2022
Q4 | $27.6M | Buy |
116,048
+15,183
| +15% | +$3.24M | 1.83% | 21 |
|
|
2022
Q3 | $20.2M | Sell |
100,865
-79,236
| -44% | -$15.1M | 1.41% | 25 |
|
|
2022
Q2 | $26.3M | Buy |
180,101
+24,516
| +16% | +$3.48M | 1.65% | 22 |
|
|
2022
Q1 | $25.4M | Buy |
155,585
+73,732
| +90% | +$11.2M | 1.28% | 29 |
|
|
2021
Q4 | $13.9M | Buy |
81,853
+72,659
| +790% | +$13.5M | 0.62% | 59 |
|
|
2021
Q3 | $1.74M | Buy |
9,194
+537
| +6% | +$101K | 0.07% | 108 |
|
|
2021
Q2 | $1.47M | Sell |
8,657
-29,764
| -77% | -$4.36M | 0.06% | 117 |
|
|
2021
Q1 | $5.42M | Sell |
38,421
-37,863
| -50% | -$5.7M | 0.23% | 85 |
|
|
2020
Q4 | $9.91M | Buy |
76,284
+5,123
| +7% | +$684K | 0.44% | 70 |
|
|
2020
Q3 | $10.4M | Buy |
71,161
+21,412
| +43% | +$3.04M | 0.52% | 56 |
|
|
2020
Q2 | $7.37M | Buy |
+49,749
| New | +$6.71M | 0.47% | 57 |
|
|
2019
Q3 | – | Sell |
-844
| Closed | -$61K | – | 120 |
|
|
2019
Q2 | $61K | Sell |
844
-115,358
| -99% | -$8.85M | ﹤0.01% | 114 |
|
|
2019
Q1 | $10.9M | Sell |
116,202
-157,403
| -58% | -$13.2M | 0.55% | 54 |
|
|
2018
Q4 | $19.9M | Buy |
273,605
+28,824
| +12% | +$2.22M | 0.96% | 39 |
|
|
2018
Q3 | $21.4M | Sell |
244,781
-42,933
| -15% | -$4.32M | 0.91% | 39 |
|
|
2018
Q2 | $28.3M | Buy |
287,714
+78,265
| +37% | +$7.76M | 1.17% | 32 |
|
|
2018
Q1 | $24.9M | Buy |
209,449
+97,895
| +88% | +$12.6M | 1.02% | 36 |
|
|
2017
Q4 | $14.2M | Buy |
+111,554
| New | +$14M | 0.61% | 63 |
|
|
2015
Q4 | – | Sell |
-116,310
| Closed | -$9.35M | – | 110 |
|
|
2015
Q3 | $9.35M | Buy |
116,310
+80,014
| +220% | +$8.89M | 0.36% | 61 |
|
|
2015
Q2 | $4.35M | Buy |
+36,296
| New | +$4.34M | 0.16% | 90 |
|
Other funds holding ALNY
